Yaniv Sneor, the co-founder of Mid Atlantic Bio Angels and part of the Ask the Investor sessions at MedCity INVEST this week, explained what his firm looks for in life science startups.
In a wide-ranging interview, Dr. Geoff Vince, the new executive director of Cleveland Clinic Innovations, discussed his plans for how the commercialization arm will operate, the technologies he thinks will drive interest and whether the pandemic has changed approaches to innovation.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Startup Founder Testimonial: Vitruvian from LaunchPad Central on Vimeo. There have been 2 or 3 courses in my entire education that have changed the way I think. This is one of those. For the past three years the National Science Foundation Innovation Corps has been teaching our nations best scientists how to build a Lean Startup. Close […]
We’ve pivoted our Lean LaunchPad / I-Corps curriculum. We’re changing the order in which we teach the business model canvas and customer development to better-fit therapeutics, diagnostics and medical devices. — Over the last three years the Lean LaunchPad class has started to replace the last century’s “how to write a business plan” classes as the foundation for entrepreneurial […]
Since 2005 startup accelerators have provided cohorts of startups with mentoring, pitch practice and product focus. However, accelerator Demo Days are a combination of graduation ceremony and pitch contest, with the uncomfortable feel of a swimsuit competition. Other than “I’ll know it when I see it,” there’s no formal way for an investor attending Demo […]
Three teams were announced as winners in the recent Design by Biomedical Undergraduate Teams (DEBUT) challenge, a biomedical engineering design competition for teams of undergraduate students. The three categories addressed the critical needs in biomedical technology, focusing on devices for diagnostics, therapeutics, and technology that can aid underserved populations and individuals with disabilities. The challenge […]
Share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health, healthcare navigation, and more.
Medtronic (MDT) is selling off endovascular technology. Volcano Corporation (VOLC) will acquire Medtronic’s Pioneer Plus diagnostic ultrasound transducer and percutaneous catheter in a deal that should close by the end of the week. Volcano will use Pioneer Plus to increase its presence in the diagnosis and treatment of peripheral arterial disease. The acquisition moves the […]
A health IT firm won the day in a city that is better known for its pharma and medical device companies. Diagnotes was awarded $25,000 in the BioCrossroads New Venture Competition Monday night in Indianapolis. The firm created the On Call program to connect hospital staff with doctors who are on duty but not at […]
A serial entrepreneur has inked a licensing agreement with three Philadelphia institutions for their technologies to develop synthetic skin from soybean proteins as well as technologies for vascular grafts and tissue regeneration. Eqalix CEO Joseph P. Connell sees applications for diabetic foot ulcers, bed sores, trauma and burns. Connell said the synthetic skin addresses the […]
A company is raising $6 million to advance the development of a natural human protein with anti-inflammatory benefits for critical care patients. BioAegis Therapeutics is developing recombinant human plasma gelsolin to restore plasma gelsolin levels in patients where it is depleted. As of last month it had raised about $500,000. The compelling characteristic of plasma […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
A biotechnology company that specializes in acute care therapeutics has shelved its development of an anticoagulant therapeutic designed to neutralize the effects of blood thinner heparin in certain situations because participants in two clinical trials experienced drops in blood pressure. PolyMedix (OTCBB:PYMX.OB) stopped enrollment in a phase 2 clinical trial for reversing the anticoagulant activity […]
A French nanomedicine company developing a novel cancer therapeutic to strategically destroy tumors in lung cancer patients to improve survival rates has forged a research collaboration with an East Coast hospital. Nanobiotix’s two-year research collaboration is with Thomas Jefferson University Hospitals in Philadelphia, the only U.S. hospital conducting a preclinical trial with nanoXray therapeutics, said […]
Amicus Therapeutics (NASDAQ:FOLD) has hired a biopharmaceutical industry veteran as chief financial officer of its business to develop treatments for lysosomal storage diseases and neurodegenerative diseases. William D. Baird III previously worked at PTC Therapeutics where he served for 10 years, seven as CFO, according to a company statement. Amicus’ lead drug undergoing phase 3 […]
Shire (NASDAQ:SHPGY) has acquired the assets of a therapeutics firm, including a vascular surgery technology undergoing phase 2 clinical trials in a move that stands to bolster its regenerative medicine division. As part of the agreement, Shire will provide Pervasis with an up-front payment, along with milestone payments tied to the drugs meeting clinical development, […]
A warning letter issued by the U.S. Food and Drug Administration has cited numerous violations by a stem cell company and claimed it did not have an appropriate license to produce stem cells. IntelliCell BioSciences in New York derives stem cells from adipose tissue, or fat cells, for treatments ranging from lower back pain to […]